Dr. David Weinstein of the University of Connecticut School of Medicine and Connecticut Children's has presented the results from a one-year clinical trial testing a new gene therapy as a treatment ...
Glycogen storage diseases (GSDs) constitute a group of inherited metabolic disorders that impair normal glycogen synthesis or degradation, resulting in the accumulation of structurally abnormal ...
When we see an individual with abnormal left ventricular hypertrophy and preexcitation, our first thought should not be HCM, it should be a glycogen-storage disease. The Seidmans are coauthors of the ...
Glycogen storage disease type III (GSD III) is a rare genetic disorder resulting from mutations in the AGL gene, which encodes the glycogen debranching enzyme (GDE). This enzyme is vital for the ...
The Morning Sun on MSN
St. Louis family hosts medical benefit for daughter with rare disease
Julianna, a 10-month-old child in St. Louis, suffers from Glycogen storage disease type III that affects 1 in 100,000 kids ...
NOVATO, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Today, Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced positive longer-term results from its Phase 3 study of DTX401 AAV gene therapy for the ...
We tapped experts and the latest research to find out how a runner's menstrual cycle could impact the way that they carb-load ...
It has been known in the scientific community since the late 1960s that the ability to perform endurance exercise is strongly influenced by the amount of pre-exercise glycogen (carbohydrate) stored in ...
Subcellular organization of bacterial cells transitioning from exponential to stationary phase has not been well investigated ...
The rare and deadly genetic liver disorder, GSD type Ia, affects children from infancy through adulthood, causing dangerously low blood sugar levels and constant dependence on glucose consumption in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback